Adding a newer medicine to the standard hormonal treatment helped women who had not reached menopause or were still going through it. Source: NYT > Business – Denise Grady
Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. Source: NYT > Business – HEATHER MURPHY
Mammogram Centers Must Tell Women if They Have Dense Breasts, F.D.A. Proposes
A new rule would require mammogram providers to let women know if they have dense breast tissue, which can hide cancer from X-rays. Source: NYT > Business – DENISE GRADY
Reports of Breast Implant Illnesses Prompt Federal Review
The Food and Drug Administration is taking another look at breast implants because of renewed safety concerns. Source: NYT > Business – DENISE GRADY and RONI CARYN RABIN
Cancer Patients Are Getting Robotic Surgery. There’s No Evidence It’s Better.
High-tech surgical robots aren’t an improvement over traditional operations, the F.D.A. warns. For some patients, the robots may be worse. Source: NYT > Business – RONI CARYN RABIN